| Original language | English (US) |
|---|---|
| Pages (from-to) | 28-29 |
| Number of pages | 2 |
| Journal | International Journal of Advances in Rheumatology |
| Volume | 9 |
| Issue number | 1 |
| State | Published - Dec 1 2011 |
ASJC Scopus subject areas
- Rheumatology
The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: Results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial. Commentary
Tom Huizinga*, Peter Nigrovic, Eric Ruderman, Hendrik Schulze-Koops
*Corresponding author for this work
Research output: Contribution to journal › Comment/debate › peer-review